ITP affects about five people per 10,000. It can be associated with other conditions that are hematologic (leukemia) or ...
The FDA expanded the approval of Cablivi to include pediatric patients 12 years and older with acquired thrombotic thrombocytopenic purpura.
The Food and Drug Administration has approved Yartemlea ® (narsoplimab-wuug) for the treatment of adult and pediatric patients aged 2 years and older with hematopoietic stem cell transplant ...
What can you tell me about the cause and treatment of immune thrombocytopenia purpura (ITP)? I am a 71-year-old male, and after lab results showed a low ...
The treatment for acquired thrombotic thrombocytopenic purpura, a rare blood disorder that causes blood clots in the small ...
Aplastic anaemia is a rare and potentially life-threatening condition that can worsen during pregnancy. Its management poses unique challenges due to risks of haemorrhage, infection and transfusion ...
Rilzabrutinib (Wayrilz; Sanofi), a BTK inhibitor, targets immune-mediated platelet destruction in immune thrombocytopenia (ITP) and has demonstrated a favorable safety profile.
Sanofi (NASDAQ:SNY) is among the ridiculously cheap stocks to buy now. On December 28, Jefferies reiterated its ‘Buy’ rating ...
Woman's World on MSN
Normal AST levels by age: Are you at risk of fatty liver disease?
A1C, LDL, HDL… the number of medical abbreviations you might see on your patient portal is enough to make you think your ...
DEAR DR. ROACH: What can you tell me about the cause and treatment of immune thrombocytopenia purpura (ITP)? I am a 71-year-old male, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback